Literature DB >> 19996120

What is the optimal treatment for biphenotypic acute leukemia?

Changcheng Zheng, Jingsheng Wu, Xin Liu, Kaiyang Ding, Xiaoyan Cai, Weibo Zhu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19996120      PMCID： PMC2791943          DOI： 10.3324/haematol.2009.014829

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  Human myeloperoxidase gene expression in acute leukemia.

Authors:  S R Zaki; G E Austin; D Swan; A Srinivasan; A H Ragab; W C Chan
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

2.  The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype.

Authors:  T Matsuo; K Kuriyama; Y Miyazaki; S Yoshida; M Tomonaga; N Emi; T Kobayashi; S Miyawaki; T Matsushima; K Shinagawa; S Honda; R Ohno
Journal:  Leukemia       Date:  2003-08       Impact factor: 11.528

3.  Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population.

Authors:  Xiao-Qian Xu; Jian-Min Wang; Shu-Qing Lü; Li Chen; Jian-Min Yang; Wei-Ping Zhang; Xian-Min Song; Jun Hou; Xiong Ni; Hui-Ying Qiu
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

4.  A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias.

Authors:  M Lübbert; W Oster; W D Ludwig; A Ganser; R Mertelsmann; F Herrmann
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

5.  Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital.

Authors:  Jeffrey E Rubnitz; Mihaela Onciu; Stanley Pounds; Sheila Shurtleff; Xueyuan Cao; Susana C Raimondi; Frederick G Behm; Dario Campana; Bassem I Razzouk; Raul C Ribeiro; James R Downing; Ching-Hon Pui
Journal:  Blood       Date:  2009-01-08       Impact factor: 22.113

6.  Acute bilineal leukemia: a rare disease with poor outcome.

Authors:  E G Weir; M Ali Ansari-Lari; D A S Batista; C A Griffin; S Fuller; B D Smith; M J Borowitz
Journal:  Leukemia       Date:  2007-07-05       Impact factor: 11.528

7.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

Authors:  M C Bene; G Castoldi; W Knapp; W D Ludwig; E Matutes; A Orfao; M B van't Veer
Journal:  Leukemia       Date:  1995-10       Impact factor: 11.528
  7 in total
  9 in total

1.  Mixed Phenotypic Acute Leukemia Presenting as Mediastinal Mass-2 Cases.

Authors:  Rig Vardhan; Jyoti Kotwal; Prosenjit Ganguli; Rehan Ahmed; Ajay Sharma; Jasjit Singh
Journal:  Indian J Hematol Blood Transfus       Date:  2015-10-29       Impact factor: 0.900

2.  Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.

Authors:  Eman O Rasekh; Randa Osman; Dalia Ibraheem; Youssef Madney; Enas Radwan; Abdallah Gameel; Ahmed Abdelhafiz; Azza Kamel; Sally Elfishawi
Journal:  Ann Hematol       Date:  2020-11-23       Impact factor: 3.673

3.  Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes.

Authors:  Hung Chang; Wen-Yu Chuang; Chien-Feng Sun; Marc R Barnard
Journal:  Diagn Pathol       Date:  2012-02-22       Impact factor: 2.644

4.  Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report.

Authors:  Meng-Yun Li; Zhi-Hong Lin; Ming-Ming Hu; Li-Qing Kang; Xiao-Xia Wu; Qi-Wei Chen; Xin Kong; Jian Zhang; Hui-Ying Qiu; De-Pei Wu
Journal:  Biomark Res       Date:  2020-08-31

5.  Epstein-Barr virus-induced CD30-positive diffuse large B-cell lymphoma in a patient with mixed-phenotypic leukemia treated with clofarabine.

Authors:  Pavan Kumar Bhamidipati; Elias Jabbour; Sergej Konoplev; Zeev Estrov; Jorge Cortes; Naval Daver
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-12-14

6.  Clinical Study of Acute Mixed-lineage Leukemia in 14 Children.

Authors:  Yaodong Zhang; Lina Tan; Xiaoling Zhang; Haiyan Wei; Qun Hu
Journal:  Iran J Pediatr       Date:  2011-12       Impact factor: 0.364

7.  The association of complex genetic background with the prognosis of acute leukemia with ambiguous lineage.

Authors:  Jin Huang; Jing Zhou; Min Xiao; Xia Mao; Li Zhu; Songya Liu; Qinlu Li; Jin Wang; Jianfeng Zhou; Haodong Cai; Gaoxiang Wang
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

Review 8.  Mixed-Phenotype Acute Leukemia: Clinical Diagnosis and Therapeutic Strategies.

Authors:  Binsah S George; Binoy Yohannan; Anneliese Gonzalez; Adan Rios
Journal:  Biomedicines       Date:  2022-08-15

9.  Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia.

Authors:  Jeffrey M Granja; Sandy Klemm; Lisa M McGinnis; Arwa S Kathiria; Anja Mezger; M Ryan Corces; Benjamin Parks; Eric Gars; Michaela Liedtke; Grace X Y Zheng; Howard Y Chang; Ravindra Majeti; William J Greenleaf
Journal:  Nat Biotechnol       Date:  2019-12-02       Impact factor: 54.908
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.